Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub‐study of the ENOKSI thromboprophylaxis RCT
Sign Up to like & getrecommendations! Published in 2020 at "Acta Anaesthesiologica Scandinavica"
DOI: 10.1111/aas.13697
Abstract: Standard subcutaneous low‐molecular‐weight heparin (LMWH) thromboprophylaxis yields low anti‐factor Xa activity in patients in the intensive care unit (ICU). The aim of the study was to assess coagulation status in ICU patients randomized to receive… read more here.
Keywords: standard subcutaneous; study; enoxaparin; intravenous infusion ... See more keywords